X T L Biopharmaceuticals reported $1.3K in Interest Expense on Debt for its fiscal quarter ending in June of 2024.





Interest Expense On Debt Change Date
Alaunos Therapeutics USD 1.07M 215K Jun/2023
Bioline Rx USD 280K 80K Dec/2025
Teva Pharmaceutical Industries USD 216M 4M Mar/2026